Effects of statins on vascular structure and function: A systematic review

被引:56
作者
Balk, EM [1 ]
Karas, RH
Jordan, HS
Kupelnick, B
Chew, P
Lau, J
机构
[1] Tufts Univ New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Boston, MA USA
[2] Tufts Univ New England Med Ctr, Div Cardiol & Mol Cardiol Res Inst, Boston, MA USA
关键词
D O I
10.1016/j.amjmed.2004.05.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Statins reduce cardiovascular events by more than can be. explained by their effects on lipids. We conducted a systematic review of how statins affect vascular structure and function, differences among statins, and correlations between the effects of statins on vascular outcomes and either lipid levels or cardiovascular outcomes. METHODS: We primarily searched MEDLINE (1980 to March 2004) to identify all studies with at least 10 Subjects that reported the effects of currently available statins on coronary artery stenosis, carotid intima-media thickness, and endothelial function (excluding studies of drug combinations and subjects with organ transplants). Meta-analyses were performed when feasible. RESULTS: Statins decrease the progression and increase the regression of coronary artery lesions and luminal narrowing. Compared with placebo, statins decrease the likelihood of coronary artery restenosis (summary risk ratio = 0.85; 95% confidence interval: 0.77 to 0.95). Statins appear to slow the progression of carotid artery intima-media thickness. Although the effect of statins on coronary endothelial function is uncertain, statins appear to improve peripheral endothelial function. There is no conclusive evidence to suggest that individual statins differ in their effects on these outcomes. Studies generally found weak or no correlation between the effects of statins on vascular outcomes and lipid levels. No study showed a correlation between vascular effect and clinical Outcome. CONCLUSION: Statins slow the progression of, and may reverse, atherosclerosis. The magnitude of these effects, however, is small compared with the effects of statins on cardiovascular events. Statins also improve measures of vascular function, which may contribute to their clinical benefits. There is insufficient evidence to suggest that individual statins differ in their vascular effects. (C) 2004 by Elsevier Inc.
引用
收藏
页码:775 / 790
页数:16
相关论文
共 82 条
[1]   Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin [J].
Alonso, R ;
Mata, P ;
De Andres, R ;
Villacastin, BP ;
Martínez-González, J ;
Badimon, L .
ATHEROSCLEROSIS, 2001, 157 (02) :423-429
[2]   Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study [J].
Baldassarre, D ;
Veglia, F ;
Gobbi, C ;
Gallus, G ;
Ventura, A ;
Crepaldi, G ;
Fisicaro, M ;
Rimondi, S ;
Ricci, G ;
Mancini, M ;
Bond, MG ;
Collatina, S ;
Sirtori, CR .
ATHEROSCLEROSIS, 2000, 151 (02) :575-583
[3]   Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review [J].
Balk, EM ;
Lau, J ;
Goudas, LC ;
Jordan, HS ;
Kupelnick, B ;
Kim, LU ;
Karas, RH .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) :670-682
[4]   The comparative effects of postoperative analgesic therapies on pulmonary outcome: Cumulative meta-analyses of randomized, controlled trials [J].
Ballantyne, JC ;
Carr, DB ;
deFerranti, S ;
Suarez, T ;
Lau, J ;
Chalmers, TC ;
Angelillo, IF ;
Mosteller, F .
ANESTHESIA AND ANALGESIA, 1998, 86 (03) :598-612
[5]   Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty [J].
Bertrand, ME ;
McFadden, EP ;
Fruchart, JC ;
VanBelle, E ;
Commeau, P ;
Grollier, G ;
Bassand, JP ;
Machecourt, J ;
Cassagnes, J ;
Mossard, JM ;
Vacheron, A ;
Castaigne, A ;
Danchin, N ;
Lablanche, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :863-869
[6]  
Bestehorn HP, 1997, EUR HEART J, V18, P226
[7]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[8]   Endothelial dysfunction: Does it matter? Is it reversible? [J].
Celermajer, DS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :325-333
[9]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[10]   PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II) [J].
CROUSE, JR ;
BYINGTON, RP ;
BOND, MG ;
ESPELAND, MA ;
CRAVEN, TE ;
SPRINKLE, JW ;
MCGOVERN, ME ;
FURBERG, CD .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (07) :455-459